| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Privia Health Group, Inc.
13D
PRVA · 74276R102
|
5.1% |
9/8/2026
Event 9/1/2026
|
||||
| Puma Growth Holdings, LLC | 5.1% | |||||
| Rubicon Founders OP GP, LP | 5.1% | |||||
| Rubicon Founders OP GP 2 LLC | 5.1% | |||||
| Rubicon Founders LLC | 5.1% | |||||
| Adam Boehler | 5.1% | |||||
| Schedule 13G · 1 security · passive | ||||||
|
Evolent Health
13G
EVH · 30050B101
|
5.2% |
11/14/2025
Event 11/13/2025
|
||||
| Rubicon Fund II LP | 4.5% | |||||
| Rubicon Fund II PF LP | 0.7% | |||||
| Rubicon OP GP II LP | 5.2% | |||||
| Rubicon OP GP II LLC | 5.2% | |||||
| Rubicon Founders LLC | 5.2% | |||||
| Boehler Adam | 5.2% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.